KMDA · Kamada Ltd
United States · RS rating 56 · As of 2026-10-14
| Price | 7.60 USD |
|---|---|
| 1-day change | -1.2% |
| RS rating (overall / 1M / 3M / 12M) | 56 / 33 / 85 / 65 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 23 / 38 / 11 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | -33.3% |
| Sales growth Q/Q | -5.0% |
| Distance from 52-week high | +18.4% |
| Market cap (USD) | $478.1M |